Julie Frearson

Opinion author

Julie Frearson is the chief scientific officer at Charles River. She has a background in early-stage drug discovery across a variety of therapeutic areas and has served on numerous boards from private to public and charitable organizations in life sciences. In her role at Charles River she has driven collaborations with venture funds and science and technology partners to future-proof the science portfolio.

In the future of AI-driven biopharma, reusable data is the most undervalued asset.